{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T21:50:59Z","timestamp":1788558659819,"version":"build-2803163510"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Medical Joint Fund of Jinan University","award":["YXZY2022032"],"award-info":[{"award-number":["YXZY2022032"]}]},{"name":"Guangzhou Science and Technology Bureau City-University Joint Project,","award":["2023A03J0569"],"award-info":[{"award-number":["2023A03J0569"]}]},{"name":"Dongguan City Social Development and Science and Technology Key Project","award":["20231800935912"],"award-info":[{"award-number":["20231800935912"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["Nos. 82272840"],"award-info":[{"award-number":["Nos. 82272840"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"DOI":"10.1186\/s12935-025-04092-3","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T18:24:30Z","timestamp":1766168670000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Discovery and validation of RAB3B as a diagnostic biomarker for prostate cancer with serum PSA below 10 ng\/mL based on a multi-omics study"],"prefix":"10.1186","volume":"26","author":[{"given":"Chongyu","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gengguo","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junliang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongling","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongming","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caiyong","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinming","family":"Di","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,19]]},"reference":[{"issue":"11","key":"4092_CR1","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1002\/ijc.33940","volume":"150","author":"C Arsov","year":"2022","unstructured":"Arsov C, Albers P, Herkommer K, Gschwend J, Imkamp F, Peters I, et al. A randomized trial of risk-adapted screening for prostate cancer in young men-results of the first screening round of the PROBASE trial. Int J Cancer. 2022;150(11):1861\u20139.","journal-title":"Int J Cancer"},{"issue":"3","key":"4092_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"Cancer J Clin"},{"issue":"16","key":"4092_CR3","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1016\/S1470-2045(15)00361-7","volume":"16","author":"H Gr\u00f6nberg","year":"2015","unstructured":"Gr\u00f6nberg H, Adolfsson J, Aly M, Nordstr\u00f6m T, Wiklund P, Brandberg Y, et al. Prostate cancer screening in men aged 50\u201369 years (STHLM3): a prospective population-based diagnostic study. Lancet Oncol. 2015;16(16):1667\u201376.","journal-title":"Lancet Oncol"},{"issue":"4","key":"4092_CR4","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.eururo.2014.10.010","volume":"67","author":"S Loeb","year":"2015","unstructured":"Loeb S, Bruinsma SM, Nicholson J, Briganti A, Pickles T, Kakehi Y, Carlsson SV, Roobol MJ. Active surveillance for prostate cancer: a systematic review of clinicopathologic variables and biomarkers for risk stratification. Eur Urol. 2015;67(4):619\u201326.","journal-title":"Eur Urol"},{"issue":"5","key":"4092_CR5","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3322\/caac.21731","volume":"72","author":"KD Miller","year":"2022","unstructured":"Miller KD, Nogueira L, Devasia T, Mariotto AB, Yabroff KR, Jemal A, Kramer J, Siegel RL. Cancer treatment and survivorship statistics, 2022. Cancer J Clin. 2022;72(5):409\u201336.","journal-title":"Cancer J Clin"},{"issue":"1","key":"4092_CR6","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.eururo.2014.08.010","volume":"68","author":"T Nordstr\u00f6m","year":"2015","unstructured":"Nordstr\u00f6m T, Vickers A, Assel M, Lilja H, Gr\u00f6nberg H, Eklund M. Comparison between the Four-kallikrein panel and prostate health index for predicting prostate cancer. Eur Urol. 2015;68(1):139\u201346.","journal-title":"Eur Urol"},{"issue":"5","key":"4092_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2015.04.039","volume":"68","author":"SA Tomlins","year":"2015","unstructured":"Tomlins SA, Groskopf J, Chinnaiyan AM. Reply to Carsten Stephan, Henning Cammann, and Klaus Jung\u2019s letter to the editor re: Scott A. Tomlins, John R. Day, Robert J. Lonigro, et al. urine TMPRSS2:ERG plus PCA3 for individualized prostate cancer risk assessment. Eur Urol. 2015;68(5):e108. https:\/\/doi.org\/10.1016\/j.eururo.2015.04.039.","journal-title":"Eur Urol"},{"issue":"4","key":"4092_CR8","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.eururo.2017.10.036","volume":"73","author":"V Cucchiara","year":"2018","unstructured":"Cucchiara V, Cooperberg MR, Dall\u2019Era M, Lin DW, Montorsi F, Schalken JA, Evans CP. Genomic markers in prostate cancer decision making. Eur Urol. 2018;73(4):572\u201382.","journal-title":"Eur Urol"},{"issue":"26","key":"4092_CR9","doi-asserted-by":"publisher","first-page":"5719","DOI":"10.1016\/j.cell.2023.11.001","volume":"186","author":"Y Li","year":"2023","unstructured":"Li Y, Di C, Song S, Zhang Y, Lu Y, Liao J, Lei B, Zhong J, Guo K, Zhang N, et al. Choroid plexus mast cells drive tumor-associated hydrocephalus. Cell. 2023;186(26):5719\u2013e57385728.","journal-title":"Cell"},{"key":"4092_CR10","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-22-3402","author":"Y Xie","year":"2023","unstructured":"Xie Y, Li P, Sun D, Qi Q, Ma S, Zhao Y, et al. DNA methylation-based testing in peripheral blood mononuclear cells enables accurate and early detection of colorectal cancer. Cancer Res. 2023;83(21):3636-3649. https:\/\/doi.org\/10.1158\/0008-5472.CAN-22-3402.","journal-title":"Cancer Res"},{"issue":"1","key":"4092_CR11","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1186\/s12864-023-09471-6","volume":"24","author":"AR Nam","year":"2023","unstructured":"Nam AR, Heo M, Lee KH, Kim JY, Won SH, Cho JY. The landscape of PBMC methylome in canine mammary tumors reveals the epigenetic regulation of immune marker genes and its potential application in predicting tumor malignancy. BMC Genomics. 2023;24(1):403.","journal-title":"BMC Genomics"},{"key":"4092_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202307744","author":"J Li","year":"2024","unstructured":"Li J, Ma J, Liu M, Li M, Zhang M, Yin W, et al. Large-scale proteome profiling identifies biomarkers associated with suspected neurosyphilis diagnosis. Advanced science (Weinheim, Baden-Wurttemberg, Germany). 2024. https:\/\/doi.org\/10.1002\/advs.202307744.","journal-title":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)"},{"issue":"1","key":"4092_CR13","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1038\/s41467-023-44503-5","volume":"15","author":"E Bahl","year":"2024","unstructured":"Bahl E, Chatterjee S, Mukherjee U, Elsadany M, Vanrobaeys Y, Lin LC, et al. Using deep learning to quantify neuronal activation from single-cell and spatial transcriptomic data. Nat Commun. 2024;15(1):779.","journal-title":"Nat Commun"},{"issue":"3","key":"4092_CR14","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2022.13421","volume":"24","author":"Y Wang","year":"2022","unstructured":"Wang Y, Shao W, Feng Y, Tang J, Wang Q, Zhang D, et al. Prognostic value and potential biological functions of ferroptosis-related gene signature in bladder cancer. Oncol Lett. 2022;24(3):301.","journal-title":"Oncol Lett"},{"issue":"22","key":"4092_CR15","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.70212","volume":"28","author":"M Pan","year":"2024","unstructured":"Pan M, Xu X, Zhang D, Cao W. Exploring the immune landscape of ccrcc: prognostic signatures and therapeutic implications. J Cell Mol Med. 2024;28(22):e70212.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"4092_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-023-01609-4","volume":"25","author":"Y Wang","year":"2023","unstructured":"Wang Y, Liu F, Sun L, Jia Y, Yang P, Guo D, et al. Association between human blood metabolome and the risk of breast cancer. Breast Cancer Res. 2023;25(1):9.","journal-title":"Breast Cancer Res"},{"issue":"9","key":"4092_CR17","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1038\/s43018-024-00820-2","volume":"5","author":"B Dong","year":"2024","unstructured":"Dong B, Xu JY, Huang Y, Guo J, Dong Q, Wang Y, Li N, Liu Q, Zhang M, Pan Q, et al. Integrative proteogenomic profiling of high-risk prostate cancer samples from Chinese patients indicates metabolic vulnerabilities and diagnostic biomarkers. Nat Cancer. 2024;5(9):1427\u201347.","journal-title":"Nat Cancer"},{"issue":"7","key":"4092_CR18","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1038\/s41588-018-0142-8","volume":"50","author":"FR Schumacher","year":"2018","unstructured":"Schumacher FR, Al Olama AA, Berndt SI, Benlloch S, Ahmed M, Saunders EJ, Dadaev T, Leongamornlert D, Anokian E, Cieza-Borrella C, et al. Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci. Nat Genet. 2018;50(7):928\u201336.","journal-title":"Nat Genet"},{"issue":"1","key":"4092_CR19","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s41467-023-36325-2","volume":"14","author":"T Hirz","year":"2023","unstructured":"Hirz T, Mei S, Sarkar H, Kfoury Y, Wu S, Verhoeven BM, et al. Dissecting the immune suppressive human prostate tumor microenvironment via integrated single-cell and spatial transcriptomic analyses. Nat Commun. 2023;14(1):663.","journal-title":"Nat Commun"},{"issue":"5","key":"4092_CR20","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1093\/ije\/dyt179","volume":"42","author":"MJ Brion","year":"2013","unstructured":"Brion MJ, Shakhbazov K, Visscher PM. Calculating statistical power in Mendelian randomization studies. Int J Epidemiol. 2013;42(5):1497\u2013501.","journal-title":"Int J Epidemiol"},{"issue":"2","key":"4092_CR21","first-page":"115","volume":"66","author":"W Chen","year":"2016","unstructured":"Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115\u201332.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"4092_CR22","first-page":"7","volume":"69","author":"RL Siegel","year":"2019","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7\u201334.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"4092_CR23","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41572-021-00249-2","volume":"7","author":"Prostate cancer","year":"2021","unstructured":"Prostate cancer. Nat Reviews Disease Primers. 2021;7(1):8.","journal-title":"Nat Reviews Disease Primers"},{"issue":"2","key":"4092_CR24","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S1470-2045(15)00518-5","volume":"17","author":"ND Shore","year":"2016","unstructured":"Shore ND, Chowdhury S, Villers A, Klotz L, Siemens DR, Phung D, van Os S, Hasabou N, Wang F, Bhattacharya S, et al. Efficacy and safety of enzalutamide versus bicalutamide for patients with metastatic prostate cancer (TERRAIN): a randomised, double-blind, phase 2 study. Lancet Oncol. 2016;17(2):153\u201363.","journal-title":"Lancet Oncol"},{"issue":"1","key":"4092_CR25","doi-asserted-by":"publisher","first-page":"5307","DOI":"10.1038\/s41467-021-25624-1","volume":"12","author":"S Taavitsainen","year":"2021","unstructured":"Taavitsainen S, Engedal N, Cao S, Handle F, Erickson A, Prekovic S, Wetterskog D, Tolonen T, Vuorinen EM, Kiviaho A, et al. Single-cell ATAC and RNA sequencing reveal pre-existing and persistent cells associated with prostate cancer relapse. Nat Commun. 2021;12(1):5307.","journal-title":"Nat Commun"},{"issue":"1","key":"4092_CR26","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s12943-020-01264-9","volume":"19","author":"X Ma","year":"2020","unstructured":"Ma X, Guo J, Liu K, Chen L, Liu D, Dong S, Xia J, Long Q, Yue Y, Zhao P, et al. Identification of a distinct luminal subgroup diagnosing and stratifying early stage prostate cancer by tissue-based single-cell RNA sequencing. Mol Cancer. 2020;19(1):147.","journal-title":"Mol Cancer"},{"issue":"1","key":"4092_CR27","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12943-023-01915-7","volume":"23","author":"P Wu","year":"2024","unstructured":"Wu P, Zhang C, Tang X, Li D, Zhang G, Zi X, Liu J, Yin E, Zhao J, Wang P, et al. Pan-cancer characterization of cell-free immune-related MiRNA identified as a robust biomarker for cancer diagnosis. Mol Cancer. 2024;23(1):31.","journal-title":"Mol Cancer"},{"key":"4092_CR28","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.ejps.2016.09.023","volume":"98","author":"L Wang","year":"2017","unstructured":"Wang L, Skotland T, Berge V, Sandvig K, Llorente A. Exosomal proteins as prostate cancer biomarkers in urine: from mass spectrometry discovery to immunoassay-based validation. Eur J Pharm Sci. 2017;98:80\u20135.","journal-title":"Eur J Pharm Sci"},{"issue":"6","key":"4092_CR29","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.eururo.2018.08.019","volume":"74","author":"J McKiernan","year":"2018","unstructured":"McKiernan J, Donovan MJ, Margolis E, Partin A, Carter B, Brown G, et al. A prospective adaptive utility trial to validate performance of a novel urine exosome gene expression assay to predict high-grade prostate cancer in patients with prostate-specific antigen 2\u201310ng\/ml at initial biopsy. Eur Urol. 2018;74(6):731\u20138.","journal-title":"Eur Urol"},{"issue":"8","key":"4092_CR30","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/nrm2728","volume":"10","author":"H Stenmark","year":"2009","unstructured":"Stenmark H. Rab GTPases as coordinators of vesicle traffic. Nat Rev Mol Cell Biol. 2009;10(8):513\u201325.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"12","key":"4092_CR31","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1093\/jnci\/djq153","volume":"102","author":"A Hendrix","year":"2010","unstructured":"Hendrix A, Maynard D, Pauwels P, Braems G, Denys H, den Van Broecke R, et al. Effect of the secretory small GTPase Rab27B on breast cancer growth, invasion, and metastasis. J Natl Cancer Inst. 2010;102(12):866\u201380.","journal-title":"J Natl Cancer Inst"},{"key":"4092_CR32","doi-asserted-by":"publisher","first-page":"140020","DOI":"10.1016\/j.chemosphere.2023.140020","volume":"341","author":"AM Aquino","year":"2023","unstructured":"Aquino AM, Alonso-Costa LG, Santos SAA, Rocha VA, Barbisan LF, Bedrat A, Justulin LA, Flaws JA, Lemos B, Scarano WR. Integrated transcriptome and proteome analysis indicates potential biomarkers of prostate cancer in offspring of pregnant rats exposed to a phthalate mixture during gestation and lactation. Chemosphere. 2023;341:140020.","journal-title":"Chemosphere"},{"issue":"1","key":"4092_CR33","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12929-016-0287-7","volume":"23","author":"HT Tzeng","year":"2016","unstructured":"Tzeng HT, Wang YC. Rab-mediated vesicle trafficking in cancer. J Biomed Sci. 2016;23(1):70.","journal-title":"J Biomed Sci"},{"key":"4092_CR34","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.biocel.2016.03.017","volume":"75","author":"Y Luo","year":"2016","unstructured":"Luo Y, Ye GY, Qin SL, Mu YF, Zhang L, Qi Y, Qiu YE, Yu MH, Zhong M. High expression of Rab3D predicts poor prognosis and associates with tumor progression in colorectal cancer. Int J Biochem Cell Biol. 2016;75:53\u201362.","journal-title":"Int J Biochem Cell Biol"},{"key":"4092_CR35","doi-asserted-by":"publisher","DOI":"10.1007\/s10528-023-10534-2","author":"J Xu","year":"2024","unstructured":"Xu J, Xue B, Gong M, Ling L, Nie S, Li F, et al. Circ_0000337 promotes the progression of cervical cancer by miR-155-5p\/RAB3B axis. Biochem Genet.2024;62(3):2195-2209 https:\/\/doi.org\/10.1007\/s10528-023-10534-2.","journal-title":"Biochem Genet"},{"issue":"2","key":"4092_CR36","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1128\/MCB.05958-11","volume":"32","author":"PY Tan","year":"2012","unstructured":"Tan PY, Chang CW, Chng KR, Wansa KD, Sung WK, Cheung E. Integration of regulatory networks by NKX3-1 promotes androgen-dependent prostate cancer survival. Mol Cell Biol. 2012;32(2):399\u2013414.","journal-title":"Mol Cell Biol"},{"issue":"7","key":"4092_CR37","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.placenta.2009.05.001","volume":"30","author":"M Ball","year":"2009","unstructured":"Ball M, Carmody M, Wynne F, Dockery P, Aigner A, Cameron I, et al. Expression of pleiotrophin and its receptors in human placenta suggests roles in trophoblast life cycle and angiogenesis. Placenta. 2009;30(7):649\u201353.","journal-title":"Placenta"},{"issue":"6635","key":"4092_CR38","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/42954","volume":"387","author":"M Geppert","year":"1997","unstructured":"Geppert M, Goda Y, Stevens CF, S\u00fcdhof TC. The small GTP-binding protein Rab3A regulates a late step in synaptic vesicle fusion. Nature. 1997;387(6635):810\u20134.","journal-title":"Nature"},{"issue":"10","key":"4092_CR39","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1002\/jcb.29948","volume":"122","author":"RD Raffaniello","year":"2021","unstructured":"Raffaniello RD. Rab3 proteins and cancer: exit strategies. J Cell Biochem. 2021;122(10):1295\u2013301.","journal-title":"J Cell Biochem"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-025-04092-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-025-04092-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-025-04092-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T01:08:15Z","timestamp":1769216895000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12935-025-04092-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,19]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4092"],"URL":"https:\/\/doi.org\/10.1186\/s12935-025-04092-3","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,19]]},"assertion":[{"value":"7 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors approved the final manuscript and the submission to this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"This study adhered to the Helsinki Declaration. Informed consent was obtained from all patients included in the paper, and data were anonymized. The Institutional Review Board at the Third Affiliated Hospital of Sun Yat-sen University approved this analysis (Approval No.: A2025-004-01).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Human Ethics approval and Consent to participate\u00a0"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"34"}}